SECreport

Form 4 NAVIDEA BIOPHARMACEUTICA For: May 13 Filed by: Latkin Jed

Navidea Biopharmaceuticals, Inc.  (NAVB) 
NASDAQ:AMEX Investor Relations: ir.navidea.com